Key result
A single 400 mg dose of oral ATP supplementation promoted greater postexercise hypotension for systolic blood pressure compared to placebo in hypertensive women.
Why the study?
Does oral ATP supplementation improve autonomic modulation and blood pressure after acute aerobic exercise in hypertensive women?
RCT (n=11)
Double-blind
Randomized
No
Does oral ATP supplementation improve autonomic modulation and blood pressure after acute aerobic exercise in hypertensive women?
Absolute Event Rate: -13.2% vs -6.1%
p-value: p=0.006
A single 400 mg oral dose of ATP before aerobic exercise promoted greater postexercise hypotension and faster recovery of parasympathetic modulation in hypertensive women.
Supports pre-exercise ATP to enhance postexercise BP control in hypertensive women; extends autonomic recovery data to clinical endpoints.
The aim of this study was to verify the autonomic modulation and blood pressure after adenosine-5'-triphosphate (ATP) supplementation associated to acute aerobic exercise in hypertensive women. Eleven hypertensive women (age, 61.8 5.0 years) completed a randomized, double blind trial: ATP supplement condition (ATP= 400 mg) or placebo. After 30 min of supplementation or placebo intake, the subjects performed 30 min of aerobic exercise (70%-75% of maximum heart rate). The autonomic modulation was assessed by heart rate variability during rest and recovery (postexercise until 30 min of recovery), the square root of the mean squared difference between adjacent RR intervals (RMSSD), standard deviation of successive values (SDNN), low frequency (LF) and high frequency (HF) were measured. The blood pressure (systolic blood pressure [SBP] and diastolic blood pressure, mmHg) were recorded at rest, immediately postexercise, post-10, post-20, and post-30 min after exercise. For RMSSD, there was statistically significant differ-ence during recovery, with higher RMSSD for ATP compared to placebo (rest= 16.4 8.5 vs. placebo= 11.6 4.0; ATP= 18.5 9.7 msec; P= 0.020). When analyzing the delta (recovery minus rest), the RMSSD (ATP= 2.1 7.2 msec vs. placebo= -4.7 7.5 msec; P= 0.009), LF (ATP= -19.8 122.7 vs. placebo= -94.1 200.2 msec 2 ; P= 0.02), and SDNN (ATP= -2.8 12.2 msec vs. placebo= -10.6 10.5 msec; P= 0.010) were higher for ATP than placebo. Furthermore, there was a greater postexercise hypotension at 20 min for ATP (SBP: ATP= -13.2 8.4 mmHg vs. placebo= -6.1 9.9 mmHg; P= 0.006). Acute ATP supplementation promoted greater postexercise hypotension for systolic blood pressure and induced faster recovery of heart rate variability in hypertensive women.
No takes yet. Share an insight, caveat, or question.
Freitas et al. (2018) conducted an RCT in Hypertension (n=11). Oral adenosine-5’-triphosphate (ATP) vs. Placebo was evaluated on Delta systolic blood pressure at 20 min post-exercise (p=0.006). A single 400 mg dose of oral ATP supplementation promoted greater postexercise hypotension for systolic blood pressure compared to placebo in hypertensive women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: